Australia's most trusted
source of pharma news
Posted 11 May 2022 AM
Melbourne-founded genomics company myDNA, backed by Arrotex boss Dennis Bastas, has acquired exercise and nutrition program 28 by Sam Wood in a $71.2 million deal.
Bastas is executive chairman and 20 per cent shareholder in myDNA Inc, which is seeking to empower consumers to unlock the data in their DNA to personalise everyday health decisions - such as how a person's genes affect the way certain prescription medicines work.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.